Financial - Capital Markets
Compare Stocks
2 / 10Stock Comparison
NMR vs DB
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
NMR vs DB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Financial - Capital Markets | Banks - Regional |
| Market Cap | $22.85B | $60.21B |
| Revenue (TTM) | $4.76T | $60.86B |
| Net Income (TTM) | $370.05B | $6.93B |
| Gross Margin | 45.6% | 49.9% |
| Operating Margin | 11.3% | 16.0% |
| Forward P/E | 9.7x | 9.3x |
| Total Debt | $17.30T | $254.81B |
| Cash & Equiv. | $4.30T | $171.62B |
NMR vs DB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Nomura Holdings, In… (NMR) | 100 | 185.8 | +85.8% |
| Deutsche Bank AG (DB) | 100 | 374.6 | +274.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NMR vs DB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NMR carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 3 yrs, beta 1.32, yield 4.8%
- Rev growth 5.6%, EPS growth 7.2%
- 141.5% 10Y total return vs DB's 101.7%
DB is the clearest fit if your priority is valuation efficiency.
- PEG 0.08 vs NMR's 0.49
- Lower P/E (9.3x vs 9.7x), PEG 0.08 vs 0.49
- Efficiency ratio 0.3% vs NMR's 0.3% (lower = leaner)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 5.6% NII/revenue growth vs DB's -8.3% | |
| Value | Lower P/E (9.3x vs 9.7x), PEG 0.08 vs 0.49 | |
| Quality / Margins | Efficiency ratio 0.3% vs NMR's 0.3% (lower = leaner) | |
| Stability / Safety | Beta 1.32 vs DB's 1.48 | |
| Dividends | 4.8% yield; 3-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +47.1% vs DB's +20.9% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs NMR's 0.3% |
NMR vs DB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
NMR vs DB — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
DB leads this category, winning 4 of 4 comparable metrics.
Income & Cash Flow (Last 12 Months)
NMR is the larger business by revenue, generating $4.76T annually — 78.2x DB's $60.9B. Profitability is closely matched — net margins range from 11.4% (DB) to 7.6% (NMR).
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $4.76T | $60.9B |
| EBITDAEarnings before interest/tax | $533.0B | $9.7B |
| Net IncomeAfter-tax profit | $370.1B | $6.9B |
| Free Cash FlowCash after capex | $0 | $0 |
| Gross MarginGross profit ÷ Revenue | +45.6% | +49.9% |
| Operating MarginEBIT ÷ Revenue | +11.3% | +16.0% |
| Net MarginNet income ÷ Revenue | +7.6% | +11.4% |
| FCF MarginFCF ÷ Revenue | -25.2% | — |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -5.5% | +3.3% |
Valuation Metrics
DB leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 8.7x trailing earnings, DB trades at a 17% valuation discount to NMR's 10.4x P/E. Adjusting for growth (PEG ratio), DB offers better value at 0.08x vs NMR's 0.53x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $22.9B | $60.2B |
| Enterprise ValueMkt cap + debt − cash | $106.0B | $158.0B |
| Trailing P/EPrice ÷ TTM EPS | 10.40x | 8.67x |
| Forward P/EPrice ÷ next-FY EPS est. | 9.69x | 9.35x |
| PEG RatioP/E ÷ EPS growth rate | 0.53x | 0.08x |
| EV / EBITDAEnterprise value multiple | 27.25x | 13.83x |
| Price / SalesMarket cap ÷ Revenue | 0.75x | 0.84x |
| Price / BookPrice ÷ Book value/share | 0.98x | 0.67x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
DB leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
NMR delivers a 10.2% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $9 for DB. DB carries lower financial leverage with a 3.18x debt-to-equity ratio, signaling a more conservative balance sheet compared to NMR's 4.49x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +10.2% | +8.7% |
| ROA (TTM)Return on assets | +0.6% | +0.5% |
| ROICReturn on invested capital | +1.4% | +2.6% |
| ROCEReturn on capital employed | +2.4% | +1.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 |
| Debt / EquityFinancial leverage | 4.49x | 3.18x |
| Net DebtTotal debt minus cash | $13.00T | $83.2B |
| Cash & Equiv.Liquid assets | $4.30T | $171.6B |
| Total DebtShort + long-term debt | $17.30T | $254.8B |
| Interest CoverageEBIT ÷ Interest expense | 0.20x | 0.34x |
Total Returns (Dividends Reinvested)
Evenly matched — NMR and DB each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DB five years ago would be worth $23,527 today (with dividends reinvested), compared to $16,851 for NMR. Over the past 12 months, NMR leads with a +47.1% total return vs DB's +20.9%. The 3-year compound annual growth rate (CAGR) favors DB at 45.9% vs NMR's 34.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -6.3% | -20.5% |
| 1-Year ReturnPast 12 months | +47.1% | +20.9% |
| 3-Year ReturnCumulative with dividends | +145.2% | +210.4% |
| 5-Year ReturnCumulative with dividends | +68.5% | +135.3% |
| 10-Year ReturnCumulative with dividends | +141.5% | +101.7% |
| CAGR (3Y)Annualised 3-year return | +34.8% | +45.9% |
Risk & Volatility
NMR leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
NMR is the less volatile stock with a 1.32 beta — it tends to amplify market swings less than DB's 1.48 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NMR currently trades 82.6% from its 52-week high vs DB's 77.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.32x | 1.48x |
| 52-Week HighHighest price in past year | $9.58 | $40.43 |
| 52-Week LowLowest price in past year | $5.48 | $26.59 |
| % of 52W HighCurrent price vs 52-week peak | +82.6% | +77.8% |
| RSI (14)Momentum oscillator 0–100 | 51.7 | 52.5 |
| Avg Volume (50D)Average daily shares traded | 2.1M | 3.5M |
Analyst Outlook
DB leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates NMR as "Hold" and DB as "Hold". Consensus price targets imply -26.8% upside for NMR (target: $6) vs -52.7% for DB (target: $15). NMR is the only dividend payer here at 4.77% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | $5.79 | $14.87 |
| # AnalystsCovering analysts | 9 | 33 |
| Dividend YieldAnnual dividend ÷ price | +4.8% | — |
| Dividend StreakConsecutive years of raises | 3 | 4 |
| Dividend / ShareAnnual DPS | $59.06 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +2.8% | 0.0% |
DB leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). NMR leads in 1 (Risk & Volatility). 1 tied.
NMR vs DB: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is NMR or DB a better buy right now?
For growth investors, Nomura Holdings, Inc.
(NMR) is the stronger pick with 5. 6% revenue growth year-over-year, versus -8. 3% for Deutsche Bank AG (DB). Deutsche Bank AG (DB) offers the better valuation at 8. 7x trailing P/E (9. 3x forward), making it the more compelling value choice. Analysts rate Nomura Holdings, Inc. (NMR) a "Hold" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NMR or DB?
On trailing P/E, Deutsche Bank AG (DB) is the cheapest at 8.
7x versus Nomura Holdings, Inc. at 10. 4x. On forward P/E, Deutsche Bank AG is actually cheaper at 9. 3x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Deutsche Bank AG wins at 0. 08x versus Nomura Holdings, Inc. 's 0. 49x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — NMR or DB?
Over the past 5 years, Deutsche Bank AG (DB) delivered a total return of +135.
3%, compared to +68. 5% for Nomura Holdings, Inc. (NMR). Over 10 years, the gap is even starker: NMR returned +141. 5% versus DB's +101. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NMR or DB?
By beta (market sensitivity over 5 years), Nomura Holdings, Inc.
(NMR) is the lower-risk stock at 1. 32β versus Deutsche Bank AG's 1. 48β — meaning DB is approximately 11% more volatile than NMR relative to the S&P 500. On balance sheet safety, Deutsche Bank AG (DB) carries a lower debt/equity ratio of 3% versus 4% for Nomura Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NMR or DB?
By revenue growth (latest reported year), Nomura Holdings, Inc.
(NMR) is pulling ahead at 5. 6% versus -8. 3% for Deutsche Bank AG (DB). On earnings-per-share growth, the picture is similar: Deutsche Bank AG grew EPS 125. 5% year-over-year, compared to 7. 2% for Nomura Holdings, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NMR or DB?
Deutsche Bank AG (DB) is the more profitable company, earning 11.
4% net margin versus 7. 6% for Nomura Holdings, Inc. — meaning it keeps 11. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DB leads at 16. 0% versus 11. 3% for NMR. At the gross margin level — before operating expenses — DB leads at 49. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NMR or DB more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Deutsche Bank AG (DB) is the more undervalued stock at a PEG of 0. 08x versus Nomura Holdings, Inc. 's 0. 49x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Deutsche Bank AG (DB) trades at 9. 3x forward P/E versus 9. 7x for Nomura Holdings, Inc. — 0. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NMR: -26. 8% to $5. 79.
08Which pays a better dividend — NMR or DB?
In this comparison, NMR (4.
8% yield) pays a dividend. DB does not pay a meaningful dividend and should not be held primarily for income.
09Is NMR or DB better for a retirement portfolio?
For long-horizon retirement investors, Nomura Holdings, Inc.
(NMR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (4. 8% yield, +141. 5% 10Y return). Both have compounded well over 10 years (NMR: +141. 5%, DB: +101. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NMR and DB?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
NMR pays a dividend while DB does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.